Meta Pixel

News and Announcements

Placer Acquires 333 Exhibition St, Melbourne for $37.5m

  • Published January 10, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • The acquisition in Melbourne’s CBD offers uninterrupted views of the World Heritage listed Carlton Gardens, and a very secure, stable income flowing from the sole tenant, The University of Melbourne.
  • Opportunities for retail investors to buy into direct commercial CBD assets are almost non-existent so we are expecting a strong level of interest from investors when the fund opens in early 2018
  • The building comprises six floors with a total of 6,528sqm of commercial office space.

To read the full announcement, please click here.

 

About Placer Property Limited

The Placer Property’s Stables Property Fund is a direct property investment that owns The Stables Shopping Centre, located in Golden Grove, an established residential suburb approximately 22 km northeast of the Adelaide CBD.

Request Offer

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now